Chris Lorson, University of Missouri-Columbia (IMAGE)

University of Missouri-Columbia

Chris Lorson, University of Missouri-Columbia

Caption

Chris Lorson and his team tested a new molecule that was found to be highly effective in animal models exhibiting spinal muscular atrophy. Now, testing of that compound is leading to a better prognosis for mice with the disease and the possibility of potential drugs.

Credit

Roger Meissen, Bond Life Sciences Center

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.